How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

A majority of educators say their districts’ career and technical education offerings are increasing, driven in large part by growing student demand. That’s according to an EdWeek Research Center ...

Select Personal Information, then Manage Parent/Guardian Access. Enter the information for the parent/guardian you'd like to invite, then click "Send Invitation." To grant access to an existing user: ...

The opening of the academic year two weeks ago, which streamed thousands of new students into the faculties for health professions, creates an optical illusion for policymakers. While demand for ...